Glypican-3 Clinical Trials in BundangGu SeongnamSi, Gyeonggi-do

A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors